Concepedia

Perttu Koskenvesa

PK

Statistics

Publications

32

Citations

2.8K

H-Index

22

Active since

2007

Affiliations

Helsinki University Hospital(Current)

University of Helsinki

Uppsala University Hospital

St Olav's University Hospital

Skåne University Hospital

Perttu Koskenvesa is an author at Helsinki University Hospital specializing in chronic myeloid leukemia therapy, oncology, and medicine.

ORCID

Publications per year

2007–2024

32

Publications

32

Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial

Johan Richter, Joëlle Guilhot, Franz Gruber et al. · The Lancet Oncology · 2018 · 611 citations · Full text

, , +11

Dasatinib crosses the blood-brain barrier and is an efficient therapy for central nervous system Philadelphia chromosome–positive leukemia

Kimmo Porkka, Perttu Koskenvesa, Tuija Lundán et al. · Blood · 2008 · 443 citations · Full text

, , +13

The EUTOS population-based registry: incidence and clinical characteristics of 2904 CML patients in 20 European Countries

Verena Hoffmann, Michele Baccarani, Joerg Hasford et al. · Leukemia · 2015 · 255 citations · Full text

, , +9

Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia

Mette Ilander, Ulla Olsson‐Strömberg, Heinrich Schlums et al. · Leukemia · 2016 · 247 citations · Full text

, , +14

Combination of pegylated IFN-α2b with imatinib increases molecular response rates in patients with low- or intermediate-risk chronic myeloid leukemia

Bengt Simonsson, Tobias Gedde‐Dahl, Berit Markevärn et al. · Blood · 2011 · 194 citations · Full text

, , +10

1–5 of 32